Persistent URL of this record https://hdl.handle.net/1887/97505
In Collections
This item can be found in the following collections:
BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk
- All authors
- Spurdle, A.B.; Whiley, P.J.; Thompson, B.; Feng, B.J.; Healey, S.; Brown, M.A.; Pettigrew, C.; Asperen, C.J. van; Ausems, M.G.E.M.; Kattentidt-Mouravieva, A.A.; Ouweland, A.M.W. van den; Lindblom, A.; Pigg, M.H.; Schmutzler, R.K.; Engel, C.; Meindl, A.; Caputo, S.; Sinilnikova, O.M.; Lidereau, R.; Couch, F.J.; Guidugli, L.; Hansen, T.V.; Thomassen, M.; Eccles, D.M.; Tucker, K.; Benitez, J.; Domchek, S.M.; Toland, A.E.; Rensburg, E.J. van; Wappenschmidt, B.; Borg, A.; Vreeswijk, M.P.G.; Goldgar, D.E.; KConFab; Dutch Belgium UV Consortium; German Consortium Hereditary; French COVAR Grp Collaborators; ENIGMA Consortium
- Date
- 2012-08-31
- Journal
- Journal of Medical Genetics
- Volume
- 49
- Issue
- 8
- Pages
- 525 - 532